ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Angel Oak Financial Strategies Income Term Trust

Angel Oak Financial Strategies Income Term Trust (FINS)

12.91
0.09
(0.70%)
Cerrado 05 Enero 3:00PM
12.93
0.02
(0.15%)
Fuera de horario: 6:59PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
12.91
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
62,206
12.8403 Rango del Día 12.94
11.80 Rango de 52 semanas 13.30
Capitalización de Mercado [m]
Precio Anterior
12.82
Precio de Apertura
12.86
Última hora de negociación
Volumen financiero
US$ 801,191
Precio Promedio Ponderado
12.8796
Volumen promedio (3 m)
100,240
Acciones en circulación
25,062,638
Rendimiento del Dividendo
10.13%
Ratio Precio/Utilidad
42.76
Beneficio por acción (BPA)
0.3
turnover
31.46M
Beneficio neto
7.58M

Acerca de Angel Oak Financial Strategies Income Term Trust

The Fund will under normal circumstances invest at least 80% of the value of its net assets plus the amount of any borrowings for investment purposes in the securities of financial institutions measured at the time of purchase. For purposes of the Fund 80% investment policy the Fund may invest in de... The Fund will under normal circumstances invest at least 80% of the value of its net assets plus the amount of any borrowings for investment purposes in the securities of financial institutions measured at the time of purchase. For purposes of the Fund 80% investment policy the Fund may invest in debt securities including subdebt unrated debt senior debt preferred securities high yield securities and TruPS equity securities including common equity preferred equity convertible securities and warrants... In pursuing its investment objective, the Fund invests primarily in debt issued by financial institutions, including subordinated debt (sub-debt), unrated debt, senior debt and high yield securities, focusing on those in the U.S. community bank sector. The Fund may also invest in common equity, preferred equity, convertible securities and warrants of these institutions. Mostrar más

Sector
Unit Inv Tr, Closed-end Mgmt
Industria
Unit Inv Tr, Closed-end Mgmt
Sede
Wilmington, Delaware, USA
Fundado
-
Angel Oak Financial Strategies Income Term Trust is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker FINS. The last closing price for Angel Oak Financial Stra... was US$12.82. Over the last year, Angel Oak Financial Stra... shares have traded in a share price range of US$ 11.80 to US$ 13.30.

Angel Oak Financial Stra... currently has 25,062,638 shares in issue. The market capitalisation of Angel Oak Financial Stra... is US$321.30 million. Angel Oak Financial Stra... has a price to earnings ratio (PE ratio) of 42.76.

FINS Últimas noticias

Angel Oak Financial Strategies Income Term Trust Declares December 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares November 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares October 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares September 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares August 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares July 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares June 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares May 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares April 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Angel Oak Financial Strategies Income Term Trust Declares March 2024 Distribution

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.109 per share for...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.020.15515903801412.8912.9712.689292512.74167527CS
40.010.07751937984512.913.1112.629853412.83440472CS
12-0.38-2.8592927012813.2913.2912.5210024012.8469783CS
260.544.3654001616812.3713.312.317135312.85743031CS
521.018.4873949579811.913.311.86187112.61700837CS
156-3.9-23.200475907216.8116.9911.236383213.01292798CS
260-7.8161-37.711388056620.726121.979311.236108514.61369019CS

FINS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Angel Oak Financial Stra...?
El precio actual de las acciones de Angel Oak Financial Stra... es US$ 12.91
¿Cuántas acciones de Angel Oak Financial Stra... están en circulación?
Angel Oak Financial Stra... tiene 25,062,638 acciones en circulación
¿Cuál es la capitalización de mercado de Angel Oak Financial Stra...?
La capitalización de mercado de Angel Oak Financial Stra... es USD 321.3M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Angel Oak Financial Stra...?
Angel Oak Financial Stra... ha negociado en un rango de US$ 11.80 a US$ 13.30 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Angel Oak Financial Stra...?
El ratio precio/beneficio de Angel Oak Financial Stra... es 42.76
¿Cuál es el ratio de efectivo a ventas de Angel Oak Financial Stra...?
El ratio de efectivo a ventas de Angel Oak Financial Stra... es 10.3
¿Cuál es la moneda de reporte de Angel Oak Financial Stra...?
Angel Oak Financial Stra... presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Angel Oak Financial Stra...?
El último ingresos anual de Angel Oak Financial Stra... es USD 31.46M
¿Cuál es el último beneficio anual de Angel Oak Financial Stra...?
El último beneficio anual de Angel Oak Financial Stra... es USD 7.58M
¿Cuál es la dirección registrada de Angel Oak Financial Stra...?
La dirección registrada de Angel Oak Financial Stra... es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿En qué sector industrial opera Angel Oak Financial Stra...?
Angel Oak Financial Stra... opera en el sector UNIT INV TR, CLOSED-END MGMT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STEMStem Inc
US$ 1.20
(54.74%)
80.12M
KUKEKuke Music Holding Limited
US$ 0.633
(44.55%)
3.9M
BPTBP Prudhoe Bay Royalty Trust
US$ 0.7265
(30.67%)
559.26k
OKLOOklo Inc
US$ 27.22
(24.58%)
23.73M
JOBYJoby Aviation Inc
US$ 9.76
(20.64%)
28.7M
CCMConcord Medical Services Holdings Ltd
US$ 4.50
(-30.23%)
123.26k
ALURAllurion Technologies Inc
US$ 7.675
(-26.41%)
193.64k
RCSPIMCO Strategic Income Fund Inc
US$ 5.74
(-24.17%)
1.93M
PCMPCM Fund Inc
US$ 6.70
(-13.77%)
481.85k
PERFPerfect Corp
US$ 2.56
(-12.33%)
328.84k
STEMStem Inc
US$ 1.20
(54.74%)
80.16M
FFord Motor Company
US$ 9.885
(2.44%)
77.2M
QBTSD Wave Quantum Inc
US$ 9.135
(-4.94%)
64.68M
ACHRArcher Aviation Inc
US$ 11.485
(20.01%)
55.75M
ABEVAmbev SA
US$ 1.7697
(-3.30%)
52.31M
devil dog 96 devil dog 96 2 minutos hace
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 2 minutos hace
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 6 minutos hace
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 6 minutos hace
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 26 minutos hace
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 29 minutos hace
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 30 minutos hace
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 31 minutos hace
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 32 minutos hace
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 33 minutos hace
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 34 minutos hace
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 35 minutos hace
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 36 minutos hace
Probably
AVXL
HokieHead HokieHead 38 minutos hace
Wrong..
TWOH
HokieHead HokieHead 38 minutos hace
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 40 minutos hace
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 41 minutos hace
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 42 minutos hace
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 42 minutos hace
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 43 minutos hace
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 44 minutos hace
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 44 minutos hace
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 47 minutos hace
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Su Consulta Reciente

Delayed Upgrade Clock